Therefore, we selected four CREB3L1-deficient breast cancer cell lines for functional analysis, two basal TNBC cell lines (HCC1806 and HCC70) and two luminal A breast cancer cell lines (HCC1428 and T47D). Here, CREB3L1 is linked to breast carcinoma.